Lung cancer screening in urban Beijing from 2014 to 2019
10.3760/cma.j.cn112150-20200817-01126
- VernacularTitle:2014—2019年北京城市癌症早诊早治项目人群肺癌筛查结果分析
- Author:
Lei YANG
1
;
Xi ZHANG
;
Shuo LIU
;
Huichao LI
;
Qingyu LI
;
Ning WANG
;
Jiafu JI
Author Information
1. 北京大学肿瘤医院暨北京市肿瘤防治研究所 北京市肿瘤防治研究办公室 恶性肿瘤发病机制及转化研究教育部重点实验室 100142
- Keywords:
Lung neoplasms;
Early diagnosis;
Screen
- From:
Chinese Journal of Preventive Medicine
2021;55(3):339-345
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To analyze the current status of lung cancer screening among residents in Urban Beijing Cancer Screening Program, 2014-2019.Methods:Based on an on-going cancer screening program launched by the National Urban Cancer Screening Program, residents aged 40 to 69 were recruited from 80 streets in six districts of Beijing (Dongcheng, Xicheng, Chaoyang, Haidian, Fengtai, and Shijingshan District) by using a cluster sampling method. Subjects who were evaluated as high-risk individuals by using the questionnaire received Low-Dose spiral Computed Tomography (LDCT) screening in designated hospitals. All participants were followed up annually using active and passive follow-up methods to obtain their health outcomes (diagnosed with lung cancer or not). The proportion of high-risk cases evaluated by using the questionnaire, clinical recall rate for receiving LDCT screening, the proportion of cases with positive pulmonary node, incidence rate, cumulative incidence rate, and the proportion of patients with stage 0 or Ⅰ were calculated. Cox proportional hazard regression model was used to estimate the hazard ratio ( HR) and 95% confidence interval (95% CI) among individuals who experienced different screening scenarios. Results:A total of 88 044 residents with the age of (57.4±7.4) with completed high-risk assessment were included in the analysis. 23.14% of participants were evaluated as high-risk individuals by using the questionnaire. The clinical recall rate was 52.26% among the high-risk individuals. The positive rate of pulmonary node detected by LDCT was 10.99%. The incidence rate of lung cancer among males and females aged 40-69 years were 172.82/100 000 person-years and 133.52/100 000 person-years, respectively after 3 years follow-up. The incidence rates increased with age ( P trend<0.001). The incidence rate of lung cancer among high-risk individuals was 259.22/100 000 person-years, with the HR ( 95%CI) about 2.27 (1.83-2.81) when compared with that among low-risk individuals. The incidence rate and cumulative incidence rate of lung cancer among individuals with positive pulmonary node detected by LDCT were 1 825.03/100 000 person-years and 4 615.38/100 000, respectively, with the HR (95% CI) about 13.80 (8.91-21.36) when compared with that among individuals with no or negative pulmonary node. The early diagnosis rate among individuals who received LDCT screening was 70.21%, which was higher than that among individuals with no LDCT screening (45.45%). Conclusion:Individuals with a high risk of lung cancer in Beijing have a better recall rate of receiving LDCT screening. Using LDCT screening among high-risk individuals is an effective strategy to detect lung cancer cases and improve the early detection rates of lung cancer in Beijing, China.
